SELLAS Life Sciences Group (RXK3.STU) Q2 2026 Earnings

12MayConfirmed
Q1 2026
Q2 2026
-0.05
-0.05
-0.05
-0.04

Details

Expected EPS
-0.0511194
Actual EPS
-0.042599500000000005
Surprise EPS
0.01
Surprise Percent
+16.67%

Description

SELLAS Life Sciences Group (RXK3.STU) has reported earnings of -0.042599500000000005 per share for Q2 2026.

0 Comments

Share your thoughts